This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$5.0M
Filings
146
Firms Hired
2
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Skin Substitute Access and Payment Reform Act
2026 · third_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $24,000 · Firm income: —
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · third_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $24,000 · Firm income: —
Matched citations: H.R. 6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · third_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $24,000 · Firm income: —
Matched citations: S. 2561
Skin Substitute Access and Payment Reform Act
2026 · second_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $33,749 · Firm income: —
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · second_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $33,749 · Firm income: —
Matched citations: H.R. 6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · second_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $33,749 · Firm income: —
Matched citations: S. 2561
Skin Substitute Access and Payment Reform Act
2026 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $80,000
Matched citations: H.R.6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $80,000
Matched citations: S. 2561
Skin Substitute Access and Payment Reform Act
2026 · first_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $14,000 · Firm income: —
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · first_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $14,000 · Firm income: —
Matched citations: H.R. 6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · first_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: $14,000 · Firm income: —
Matched citations: S. 2561
Skin Substitute Access and Payment Reform Act
2026 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $20,000
Matched citations: H.R.6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Client expense: — · Firm income: $20,000
Matched citations: S. 2561
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5304
Skin Substitute Access and Payment Reform Act
2025 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5768
Skin Substitute Access and Payment Reform Act of 2025
2025 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products
Client expense: — · Firm income: $70,000
Matched citations: S. 2561
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products
Client expense: — · Firm income: $70,000
Matched citations: S. 2587
Skin Substitute Access and Payment Reform Act of 2025
2025 · third_quarter · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Client expense: — · Firm income: $70,000
Matched citations: S. 2561
Skin Substitute Access and Payment Reform Act of 2025
2025 · third_quarter · Firm: ORGANOGENESIS INC.
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill
Client expense: $300,000 · Firm income: —
Matched citations: S. 2561
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Food and Drug Administration policy on chronic wound healing products S. 4348 (FDASLA Act of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 7667 (Food and Drug Amendments of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 2617 (Consolidated Appropriations Act, 2023), Division FF, Title III, regarding Food and Drug Administration policy on chronic wound healing products
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2617
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Food and Drug Administration policy on chronic wound healing products S. 4348 (FDASLA Act of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 7667 (Food and Drug Amendments of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 2617 (Consolidated Appropriations Act, 2023), Division FF, Title III, regarding Food and Drug Administration policy on chronic wound healing products
Client expense: — · Firm income: $10,000
Matched citations: H.R. 7667
Food and Drug Administration policy on chronic wound healing products S. 4348 (FDASLA Act of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 7667 (Food and Drug Amendments of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 2617 (Consolidated Appropriations Act, 2023), Division FF, Title III, regarding Food and Drug Administration policy on chronic wound healing products
Client expense: — · Firm income: $10,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: ORGANOGENESIS INC.
Food and Drug Administration policy on chronic wound healing products S. 4348 (FDASLA Act of 2002), regarding Food and Drug Administration policy on chronic wound healing products H.R. 7667 (Food and Drug Amendments of 2022), regarding Food and Drug Administration policy on chronic wound healing products H.R. 2617 (Consolidated Appropriations Act, 2023), Division FF, Title III, regarding Food and Drug Administration policy on chronic wound healing products
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 2617
Source: Senate LDA